A decision theoretical modeling for Phase III investments and drug licensing.
Saved in:
| Title: | A decision theoretical modeling for Phase III investments and drug licensing. |
|---|---|
| Authors: | Miller F; a Department of Statistics , Stockholm University , Stockholm , Sweden., Burman CF; b Biometrics & Information Science , AstraZeneca R&D , Mölndal , Sweden.; c Department of Mathematical Sciences , Chalmers University of Technology and Göteborg University , Gothenburg , Sweden. |
| Source: | Journal of biopharmaceutical statistics [J Biopharm Stat] 2018; Vol. 28 (4), pp. 698-721. Date of Electronic Publication: 2017 Oct 20. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5711 (Electronic) Linking ISSN: 10543406 NLM ISO Abbreviation: J Biopharm Stat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
